![Noah Berkowitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Noah Berkowitz
Directeur Général chez
HaptoGuard, Inc.
Fortune : 2 M $ au 31/05/2026
Profil
Noah Berkowitz is the founder of Physician's Choice, Inc. Currently, Dr. Berkowitz is President & Chief Executive Officer at HaptoGuard, Inc. Formerly, Dr. Berkowitz was Chief Medical Officer at Arvinas, Inc. from 2024 to 2026, President, Chief Executive Officer & Secretary at Synvista Therapeutics, Inc. from 2006 to 2012, Director at Poseida Therapeutics, Inc., Vice President-Clinical Development at IMPATH, Inc., Consultant at Predix Pharmaceuticals, Inc., Consultant at Teva Pharmaceuticals USA, Inc., and Senior Vice President & Head-Hematology at Bristol Myers Squibb Co. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARVINAS, INC. 0,3% | 11/05/2026 | 191 395 ( 0,3% ) | 2 M $ | 31/05/2026 |
Postes actifs de Noah Berkowitz
| Sociétés | Poste | Début |
|---|---|---|
HaptoGuard, Inc.
 HaptoGuard, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Directeur Général | - |
Anciens postes connus de Noah Berkowitz
| Sociétés | Poste | Fin |
|---|---|---|
| ARVINAS, INC. | Directeur Technique/Scientifique/R&D | 03/07/2026 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| POSEIDA THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
IMPATH, Inc.
 IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Directeur Technique/Scientifique/R&D | - |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Corporate Officer/Principal | - |
Formation de Noah Berkowitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Synvista Therapeutics, Inc.
 Synvista Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases of cardiovascular aging and diabetes complications | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
IMPATH, Inc.
IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Health Services |
HaptoGuard, Inc.
HaptoGuard, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physician's Choice, Inc.
 Physician's Choice, Inc. Internet Software/ServicesTechnology Services Provides postclinical, premarketing, cost-benefit analysis to biotech companies | Technology Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Choisissez Zonebourse 
